Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review
Cassidy Scott, Stefan Hall, Juan Zhou, Christian Lehmann
Journal of Clinical Medicine, doi:10.3390/jcm13010227
) is a highly contagious illness caused by the SARS-CoV-2 virus. The clinical presentation of COVID-19 is variable, often including symptoms such as fever, cough, headache, fatigue, and an altered sense of smell and taste. Recently, post-acute "long" COVID-19 has emerged as a concern, with symptoms persisting beyond the acute infection. Vaccinations remain one of the most effective preventative methods against severe COVID-19 outcomes and the development of long-term COVID-19. However, individuals with underlying health conditions may not mount an adequate protective response to COVID-19 vaccines, increasing the likelihood of severe symptoms, hospitalization, and the development of long-term COVID-19 in high-risk populations. This review explores the potential therapeutic role of cannabinoids in limiting the susceptibility and severity of infection, both pre-and post-SARS-CoV-19 infection. Early in the SARS-CoV-19 infection, cannabinoids have been shown to prevent viral entry, mitigate oxidative stress, and alleviate the associated cytokine storm. Post-SARS-CoV-2 infection, cannabinoids have shown promise in treating symptoms associated with post-acute long COVID-19, including depression, anxiety, post-traumatic stress injury, insomnia, pain, and decreased appetite. While current research primarily focuses on potential treatments for the acute phase of COVID-19, there is a gap in research addressing therapeutics for the early and post-infectious phases. This review highlights the potential for future research to bridge this gap by investigating cannabinoids and the endocannabinoid system as a potential treatment strategy for both early and post-SARS-CoV-19 infection.
Conflicts of Interest: The authors declare no conflicts of interest.
References
Alam, Czajkowsky, SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities, Cytokine Growth Factor Rev,
doi:10.1016/j.cytogfr.2021.11.001Amini, Karimi, Talebi, Piri, The Association of COVID-19 and Reactive Oxygen Species Modulator 1 (ROMO1) with Oxidative Stress, Chonnam Med. J,
doi:10.4068/cmj.2022.58.1.1Anmar, Tixagevimab and Cilgavimab: Can We See More Recommendations for Monoclonal Antibodies beyond COVID-19 Vaccination, Disaster Med. Public Health Prep,
doi:10.1017/dmp.2022.150Atalay, Jarocka-Karpowicz, Skrzydlewskas, Antioxidative and anti-inflammatory properties of cannabidiol, Antioxidants,
doi:10.3390/antiox9010021Basha, Sankaranarayanan, β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats, Chem. Biol. Interact,
doi:10.1016/j.cbi.2015.12.019Beal, Olson, Laubenstein, Morales, Bellman et al., Medical cannabinoids: A pharmacology-based systematic review and meta-analysis for all relevant medical indications, J. Pain Symptom Manag,
doi:10.1186/s12916-022-02459-1Bergamaschi, Helena, Queiroz, Hortes, Chagas et al., Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients, Neuropsychopharmacology,
doi:10.1038/npp.2011.6Blake, Robson, Ho, Jubb, Mccabe, Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis, Rheumatology,
doi:10.1093/rheumatology/kei183Bruni, Della Pepa, Oliaro-Bosso, Pessione, Gastaldi et al., Cannabinoid delivery systems for pain and inflammation treatment, Molecules,
doi:10.3390/molecules23102478Cameron, Watson, Robinson, Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: A retrospective evaluation, J. Clin. Psychopharmacol,
doi:10.1097/JCP.0000000000000180Channappanavar, Fehr, Zheng, Wohlford-Lenane, Abrahante et al., IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes, J. Clin. Investig,
doi:10.1172/JCI126363Chen, Cui, Caffrey, Rong, Du, Small molecule inhibitors of influenza virus entry, Pharmaceuticals,
doi:10.3390/ph14060587Choudhury, Tariq, Jena, Kinzelman, Vesely et al., Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis, Ther. Adv. Vaccines,
doi:10.1177/17562848221118403Chung, Bok, Huh, Park, Yoon et al., Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation, J. Immunol,
doi:10.4049/jimmunol.1102435Coomes, Haghbayan, Interleukin-6 in COVID-19: A systematic review and meta-analysis, Rev. Med. Virol,
doi:10.1002/rmv.2141Cooray, Gupta, Suphioglu, Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: A Review, Mol. Neurobiol,
doi:10.1007/s12035-020-02054-6Cristino, Bisogno, Di Marzo, Cannabinoids and the expanded endocannabinoid system in neurological disorders, Nat. Rev. Neurol,
doi:10.1038/s41582-019-0284-zDipatrizio, Ja, ∆ 9 -THC induced hyperphagia and tolerance assessment: Interactions between the CB 1 receptor agonist ∆ 9 -THC and the CB 1 receptor antagonist SR-141716 (rimonabant) in rats, Behav. Pharmacol
Duca, Ottolenghi, Coppola, Rinaldo, Dei Cas et al., Differential redox state and iron regulation in chronic obstructive pulmonary disease, acute respiratory distress syndrome and coronavirus disease 2019, Antioxidants,
doi:10.3390/antiox10091460Ettman, Abdalla, Cohen, Sampson, Vivier et al., Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic, JAMA Netw. Open,
doi:10.1001/jamanetworkopen.2020.19686Feingold, Weinstein, Cannabis and Depression
Foster, Pickering, Neil, Inhibiting the Ins and Outs of HIV replication: Cell-intrinsic antiretroviral restrictions at the plasma membrane, Front. Immunol,
doi:10.3389/fimmu.2017.01853Fraser, The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD), CNS Neurosci. Ther,
doi:10.1111/j.1755-5949.2008.00071.xGain, Song, Angtuaco, Satta, Kelesidis, The role of oxidative stress in the pathogenesis of infections with coronaviruses, Front. Microbiol,
doi:10.3389/fmicb.2022.1111930Gomes, Resstel, Guimarães, The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors, Psychopharmacology,
doi:10.1007/s00213-010-2036-zGuimarães, Chiaretti, Graeff, Zuardi, Antianxiety effect of cannabidiol in the elevated plus-maze, Psychopharmacology,
doi:10.1007/BF02244012Harris, Rousseau, Wanas, Radwan, Caldwell et al., Role of Cannabinoids and Terpenes in Cannabis-Mediated Analgesia in Rats, Cannabis Cannabinoid Res,
doi:10.1089/can.2018.0054Henry, Lippi, Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports, J. Crit. Care,
doi:10.1016/j.jcrc.2020.03.011Hoffenberg, Mcwilliams, Mikulich-Gilbertson, Murphy, Lagueux et al., Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease, J. Pediatr,
doi:10.1016/j.jpeds.2018.03.041Hsieh, Pai, Chandran, Hooker, Zhu et al., Central and peripheral sites of action for CB 2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats, Br. J. Pharmacol,
doi:10.1111/j.1476-5381.2010.01046.xHussman, Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention, Front. Pharmacol,
doi:10.3389/fphar.2020.01169Jia, Ma, Wu, Zhang, Zhang et al., Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase, Oxid. Med. Cell. Longev,
doi:10.1155/2014/893516Khodadadi, Salles, Jarrahi, Chibane, Costigliola et al., Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA, Cannabis Cannabinoid Res,
doi:10.1089/can.2020.0043Khomich, Kochetkov, Bartosch, Ivanov, Redox biology of respiratory viral infections, Viruses,
doi:10.3390/v10080392Kleckner, Kleckner, Kamen, Tejani, Janelsins et al., Opportunities for cannabis in supportive care in cancer, Ther. Adv. Med. Oncol,
doi:10.1177/1758835919866362Lal, Prasad, Ryan, Tangri, Silverberg et al., Cannabis use amongst patients with inflammatory bowel disease, Eur. J. Gastroenterol. Hepatol,
doi:10.1097/MEG.0b013e328349bb4cLee, Clough, Jaragba, Conigrave, Patton, Heavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern Territory, Med. J. Aust,
doi:10.5694/j.1326-5377.2008.tb01803.xLombardo, Foppiani, Peretti, Mangiavini, Battezzati et al., Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study, Open Forum Infect. Dis,
doi:10.1093/ofid/ofab384Machado Rocha, Stéfano, De Cássia Haiek, Rosa Oliveira, Da Silveira, Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Systematic review and meta-analysis, Eur. J. Cancer Care,
doi:10.1111/j.1365-2354.2008.00917.xMalik, Bayman, Valestin, Rizvi-Toner, Hashmi et al., Dronabinol increases pain threshold in patients with functional chest pain: A pilot double-blind placebo-controlled trial, Dis. Esophagus,
doi:10.1111/dote.12455Mangoo, Erridge, Holvey, Coomber, Barros et al., Assessment of clinical outcomes of medicinal cannabis therapy for depression: Analysis from the UK Medical Cannabis Registry, Expert Rev. Neurother,
doi:10.1080/14737175.2022.2161894Martin, Strickland, Schlienz, Munson, Jackson et al., Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial, Front. Psychiatry,
doi:10.3389/fpsyt.2021.729800Martin, Tsou, Walker, Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla, Neurosci. Lett,
doi:10.1016/S0304-3940(98)00044-5Meiri, Jhangiani, Vredenburgh, Barbato, Carter et al., Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting, Curr. Med. Res. Opin,
doi:10.1185/030079907X167525Mertz Schou, Joca, Wegener, Bay-Richter, Psychiatric and neuropsychiatric sequelae of COVID-19-A systematic review, Brain Behav. Immun,
doi:10.1016/j.bbi.2021.07.018Mohammed, Alghetaa, Miranda, Wilson, Singh et al., ∆9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression, Int. J. Mol. Sci,
doi:10.3390/ijms21176244Moreira, Aguiar, Guimarães, Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test, Prog. Neuro-Psychopharmacol. Biol. Psychiatry,
doi:10.1016/j.pnpbp.2006.06.004Naftali, Bar-Lev, Schleider, Dotan, Lansky et al., Cannabis induces a clinical response in patients with crohn's disease: A prospective placebo-controlled study, Clin. Gastroenterol. Hepatol,
doi:10.1016/j.cgh.2013.04.034Naftali, Lev, Yablekovitz, Half, Konikoff, Treatment of Crohn's disease with Cannabis: An observational study, Isr. Med. Assoc. J
Nguyen Dinh, Montezano, Burger, Touyz, Angiotensin II, NADPH oxidase, and redox signaling in the vasculature, Antioxidants Redox Signal,
doi:10.1089/ars.2012.4641Nurmikko, Serpell, Hoggart, Toomey, Morlion et al., Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial, Pain,
doi:10.1016/j.pain.2007.08.028O'sullivan, Stevenson, Laviolette, Could cannabidiol be a treatment for coronavirus disease-19-related anxiety disorders?, Cannabis Cannabinoid Res,
doi:10.1089/can.2020.0102Onaivi, Green, Martin, Pharmacological characterization of cannabinoids in the elevated plus maze, J. Pharmacol. Exp. Ther
Pan, Mukhopadhyay, Rajesh, Patel, Mukhopadhyay et al., Cannabidiol attenuates cisplatin-Lnduced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death, J. Pharmacol. Exp. Ther,
doi:10.1124/jpet.108.147181Penzel, Antonucci, Betz, Sanfelici, Weiske et al., Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis, Neuropsychopharmacology,
doi:10.1038/s41386-021-00977-9Phatak, Rojas-Velasquez, Porto, Pashankar, Prevalence and Patterns of Marijuana Use in Young Adults with Inflammatory Bowel Disease, J. Pediatr. Gastroenterol. Nutr,
doi:10.1097/MPG.0000000000001474Pini, Guerzoni, Cainazzo, Ferrari, Sarchielli et al., Nabilone for the treatment of medication overuse headache: Results of a preliminary double-blind, active-controlled, randomized trial, J. Headache Pain,
doi:10.1007/s10194-012-0490-1Pinsger, Schimetta, Volc, Hiermann, Riederer et al., Benefits of an Add-On Treatment with the Synthetic Cannabinomimetic Nabilone on Patients with Chronic Pain-A Randomized Controlled Trial, Eur. J. Pain,
doi:10.1016/S1090-3801(06)60627-7Qin, Zhou, Hu, Zhang, Yang et al., Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China, Clin. Infect. Dis,
doi:10.1093/cid/ciaa248Rabi, Al Zoubi, Al-Nasser, Kasasbeh, Salameh, SARS-CoV-2 and coronavirus disease 2019: What we know so far, Pathogens,
doi:10.3390/pathogens9030231Rajesh, Mukhopadhyay, Bátkai, Arif, Varga et al., Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis, GeroScience,
doi:10.1007/s11357-022-00565-9Rajesh, Mukhopadhyay, Bátkai, Haskó, Liaudet et al., Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption, Am. J. Physiol.-Heart Circ. Physiol,
doi:10.1152/ajpheart.00236.2007Resstel, Joca, Moreira, Corrêa, Guimarães, Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats, Behav. Brain Res,
doi:10.1016/j.bbr.2006.05.016Roitman, Mechoulam, Cooper-Kazaz, Shalev, Preliminary, open-label, pilot study of add-on oral ∆9tetrahydrocannabinol in chronic post-traumatic stress disorder, Clin. Drug Investig,
doi:10.1007/s40261-014-0212-3Romeyke, Westfal, Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder, Med. Cannabis Cannabinoids,
doi:10.1159/000527521Sartim, Guimarães, Joca, Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors, Behav. Brain Res,
doi:10.1016/j.bbr.2016.01.033Scherma, Lisa Muntoni, Riedel, Fratta, Fadda, Cannabinoids and their therapeutic applications in mental disorders, Dialogues Clin. Neurosci,
doi:10.31887/DCNS.2020.22.3/pfaddaScherma, Masia, Deidda, Fratta, Tanda et al., New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders, Medicines,
doi:10.3390/medicines5040107Shiplo, Asbridge, Leatherdale, Hammond, Medical cannabis use in Canada: Vapourization and modes of delivery, Harm Reduct. J,
doi:10.1186/s12954-016-0119-9Silote, Gatto, Eskelund, Guimarães, Wegener et al., Strain-, Sex-, and Time-Dependent Antidepressantlike Effects of Cannabidiol, Pharmaceuticals,
doi:10.3390/ph14121269Smith, Azariah, Lavender, Stoner, Bettiol, Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy, Cochrane Database Syst. Rev,
doi:10.1002/14651858.CD009464.pub2Storr, Devlin, Kaplan, Panaccione, Andrews, Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease, Inflamm. Bowel Dis,
doi:10.1097/01.MIB.0000440982.79036.d6Suryavanshi, Zaiachuk, Pryimak, Kovalchuk, Kovalchuk, Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro, Cells,
doi:10.3390/cells11091391Svendsen, Jensen, Bach, Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial, BMJ,
doi:10.1136/bmj.38149.566979.AESykes, Holdsworth, Jawad, Gunasekera, Morice et al., Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It, Lung
Taquet, Luciano, Geddes, Harrison, Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA, Lancet Psychiatry,
doi:10.1016/S2215-0366(20)30462-4Ueberall, Vila Silván, Essner, Mueller-Schwefe, Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry, Pain Med,
doi:10.1093/pm/pnab263Van Breemen, Muchiri, Bates, Weinstein, Leier et al., Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants, J. Nat. Prod,
doi:10.1021/acs.jnatprod.1c00946Walsh, Maddison, Rankin, Murray, Mcardle et al., Treating insomnia symptoms with medicinal cannabis: A randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo, Sleep,
doi:10.1093/sleep/zsab149Watson, Campbell, Hopkins, Smith, Kelly et al., Altered smell and taste: Anosmia, parosmia and the impact of long COVID-19, PLoS ONE,
doi:10.1371/journal.pone.0256998Whiting, Wolff, Deshpande, Di Nisio, Duffy et al., Cannabinoids for medical use: A systematic review and meta-analysis, JAMA,
doi:10.1001/jama.2015.6358Wilsey, Marcotte, Deutsch, Gouaux, Sakai et al., Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain, J. Pain,
doi:10.1016/j.jpain.2012.10.009Wilsey, Marcotte, Deutsch, Zhao, Prasad et al., An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease, J. Pain,
doi:10.1016/j.jpain.2016.05.010Xu, Zhong, Deng, Peng, Dan et al., High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int. J. Oral Sci,
doi:10.1038/s41368-020-0074-xYankelevitch-Yahav, Franko, Huly, Doron, The Forced Swim Test as a Model of Depressive-like Behavior, J. Vis. Exp,
doi:10.3791/52587Yuill, Hale, Guindon, Morgan, Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain, Mol. Pain,
doi:10.1177/1744806917728227Zanelati, Biojone, Moreira, Guimarães, Joca, Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors, Br. J. Pharmacol,
doi:10.1111/j.1476-5381.2009.00521.xZou, Kumar, Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system, Int. J. Mol. Sci,
doi:10.3390/ijms19030833Zuardi, Cosme, Graeff, Guimarães, Effects of ipsapirone and cannabidiol on human experimental anxiety, J. Psychopharmacol,
doi:10.1177/026988119300700112
